MedPath

Variability of Daily Iodine Intake: The Effects of Intra- and Inter-individual Variability in Iodine Nutrition Studies

Completed
Conditions
Iodine Deficiency
Interventions
Other: No intervention
Registration Number
NCT03731312
Lead Sponsor
Swiss Federal Institute of Technology
Brief Summary

Iodine status in populations is assessed using urinary iodine concentration (UIC) measured in spot urine samples. The iodine intake is classified as deficient, sufficient, or excessive iodine based on the median UIC (mUIC). However, this approach has limitations, as it does not quantify the prevalence of individuals with habitually deficient or excess iodine intakes. The EAR cut-point method has the potential to quantify prevalence of iodine deficiency and excess. However, little is known about the effects of the inter- and intra-individual variance of UIC.

The aim of the study is to quantify the intra-individual variability in dietary iodine intake. The overall goal is to estimate the prevalence of iodine deficiency and excess in the study population and propose sample size recommendations for future iodine nutrition population studies. The results will provide evidence guiding international recommendations for iodine nutrition studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
206
Inclusion Criteria
  • Non-pregnant
  • Non-lactating
  • Non-smoking
  • Residence in Switzerland ≥12 months
  • Generally healthy
  • No family history of goiter
  • No exposure to iodine containing contrast agents during the last 12 months - Informed consent given
Exclusion Criteria
  • Participant is not able to understand the study information or procedure, e.g. due to linguistic barriers

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Study groupNo interventionWe will collect two repeated spot urine samples, a DBS sample and obtain weight in all 600 study participants. In a randomly selected subsample (n=200) a third repeat spot urine sample and one 24 h urine will additionally be collected.
Primary Outcome Measures
NameTimeMethod
Estimated daily urinary iodine excretion7 days

Estimated urinary iodine excretion (µg/day) will be obtained from urinary iodine concentration (UIC) and urinary creatinine concentration (UCC) measured in two repeat spot urine samples collected within 7 days

Secondary Outcome Measures
NameTimeMethod
Measured daily iodine excretion1 day

Measured daily iodine excretion (µg/day) will be obtained from urinary iodine concentration (UIC) and urine volume in a 24 h urine collection

Thyroid function test TSH1 day

TSH concentration (mU/L) measured in dried blood spots

Thyroid function test total T41 day

Total T4 concentration (nmol/L) measured in dried blood spots

Thyroid function test Tg1 day

Tg concentration (µg/L) measured in dried blood spots

Trial Locations

Locations (1)

ETH Zurich

🇨🇭

Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath